C

Cellectis SA
D

CLLS

1.48500
USD
-0.03
(-1.98%)
مغلق
حجم التداول
3,592
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
148,639,401
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALLO
    -0.03000
    (-1.63%)
    1.81000 USD
    B
    BEAM
    0.030
    (0.13%)
    23.440 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    F
    FATE
    0.02000
    (1.60%)
    1.27000 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.